MannKind Corporation 2.5% 01-MAR-2026MannKind Corporation 2.5% 01-MAR-2026MannKind Corporation 2.5% 01-MAR-2026

MannKind Corporation 2.5% 01-MAR-2026

No trades
See on Supercharts

Key terms


Outstanding amount
‪230.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−19.83%
Maturity date
Mar 1, 2026
Term to maturity
1 year

About MannKind Corporation 2.5% 01-MAR-2026


Sector
Health Technology
Issue date
Mar 15, 2022
FIGI
BBG00ZHDCX27
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.